UniProt ID | CE024_HUMAN | |
---|---|---|
UniProt AC | Q7Z6I8 | |
Protein Name | UPF0461 protein C5orf24 | |
Gene Name | C5orf24 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 188 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MMHPVASSNPAFCGPGKPSCLNEDAMRAADQFDIYSSQQSKYSHTVNHKPMVCQRQDPLNETHLQTTSGRSIEIKDELKKKKNLNRSGKRGRPSGTTKSAGYRTSTGRPLGTTKAAGFKTSPGRPLGTTKAAGYKVSPGRPPGSIKALSRLADLGYGCGTAAFPYPMMHGRAVHGVEETSSEVKPPNE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
17 | Acetylation | PAFCGPGKPSCLNED CCCCCCCCHHHCCHH | 36.57 | 25953088 | |
35 | Phosphorylation | AADQFDIYSSQQSKY HHHHHCCCCCCCHHC | 12.24 | 21945579 | |
36 | Phosphorylation | ADQFDIYSSQQSKYS HHHHCCCCCCCHHCC | 23.23 | 21945579 | |
37 | Phosphorylation | DQFDIYSSQQSKYSH HHHCCCCCCCHHCCC | 18.44 | 21945579 | |
40 | Phosphorylation | DIYSSQQSKYSHTVN CCCCCCCHHCCCCCC | 26.39 | 21945579 | |
41 (in isoform 2) | Ubiquitination | - | 46.57 | 21890473 | |
41 (in isoform 1) | Ubiquitination | - | 46.57 | 21890473 | |
41 | Ubiquitination | IYSSQQSKYSHTVNH CCCCCCHHCCCCCCC | 46.57 | 21890473 | |
49 | Acetylation | YSHTVNHKPMVCQRQ CCCCCCCCCCEEECC | 29.61 | 23749302 | |
49 | Ubiquitination | YSHTVNHKPMVCQRQ CCCCCCCCCCEEECC | 29.61 | 29967540 | |
71 | Phosphorylation | LQTTSGRSIEIKDEL CCCCCCCCEECHHHH | 28.26 | 27134283 | |
75 | Sumoylation | SGRSIEIKDELKKKK CCCCEECHHHHHHHH | 32.15 | - | |
75 | Ubiquitination | SGRSIEIKDELKKKK CCCCEECHHHHHHHH | 32.15 | 32015554 | |
75 | Sumoylation | SGRSIEIKDELKKKK CCCCEECHHHHHHHH | 32.15 | 28112733 | |
94 | Phosphorylation | SGKRGRPSGTTKSAG CCCCCCCCCCCCCCC | 47.62 | - | |
96 | Phosphorylation | KRGRPSGTTKSAGYR CCCCCCCCCCCCCCC | 35.07 | - | |
97 | Phosphorylation | RGRPSGTTKSAGYRT CCCCCCCCCCCCCCC | 26.91 | 22210691 | |
102 | Phosphorylation | GTTKSAGYRTSTGRP CCCCCCCCCCCCCCC | 15.50 | 22210691 | |
104 | Phosphorylation | TKSAGYRTSTGRPLG CCCCCCCCCCCCCCC | 23.35 | 29209046 | |
105 | Phosphorylation | KSAGYRTSTGRPLGT CCCCCCCCCCCCCCC | 21.62 | 25627689 | |
106 | Phosphorylation | SAGYRTSTGRPLGTT CCCCCCCCCCCCCCC | 36.28 | 29209046 | |
112 | Phosphorylation | STGRPLGTTKAAGFK CCCCCCCCCCCCCCC | 32.57 | 29209046 | |
113 | Phosphorylation | TGRPLGTTKAAGFKT CCCCCCCCCCCCCCC | 19.52 | 29209046 | |
114 | Ubiquitination | GRPLGTTKAAGFKTS CCCCCCCCCCCCCCC | 35.76 | 23000965 | |
119 | Acetylation | TTKAAGFKTSPGRPL CCCCCCCCCCCCCCC | 47.37 | 25953088 | |
119 | Ubiquitination | TTKAAGFKTSPGRPL CCCCCCCCCCCCCCC | 47.37 | 23000965 | |
120 | Phosphorylation | TKAAGFKTSPGRPLG CCCCCCCCCCCCCCC | 37.58 | 25159151 | |
121 | Phosphorylation | KAAGFKTSPGRPLGT CCCCCCCCCCCCCCC | 26.41 | 25159151 | |
128 | Phosphorylation | SPGRPLGTTKAAGYK CCCCCCCCCCCCCCC | 32.57 | 23403867 | |
129 | Phosphorylation | PGRPLGTTKAAGYKV CCCCCCCCCCCCCCC | 19.52 | 23403867 | |
134 | Phosphorylation | GTTKAAGYKVSPGRP CCCCCCCCCCCCCCC | 11.95 | 23403867 | |
137 | Phosphorylation | KAAGYKVSPGRPPGS CCCCCCCCCCCCCCH | 19.93 | 25159151 | |
137 (in isoform 2) | Phosphorylation | - | 19.93 | 25159151 | |
144 | Phosphorylation | SPGRPPGSIKALSRL CCCCCCCHHHHHHHH | 27.04 | 25159151 | |
146 | Ubiquitination | GRPPGSIKALSRLAD CCCCCHHHHHHHHHH | 45.00 | 23000965 | |
146 (in isoform 1) | Ubiquitination | - | 45.00 | 21890473 | |
179 | Phosphorylation | AVHGVEETSSEVKPP CCCCCCCCCCCCCCC | 24.85 | 23663014 | |
180 | Phosphorylation | VHGVEETSSEVKPPN CCCCCCCCCCCCCCC | 27.99 | 23663014 | |
181 | Phosphorylation | HGVEETSSEVKPPNE CCCCCCCCCCCCCCC | 54.55 | 23663014 | |
184 | Ubiquitination | EETSSEVKPPNE--- CCCCCCCCCCCC--- | 51.19 | 33845483 | |
184 | Sumoylation | EETSSEVKPPNE--- CCCCCCCCCCCC--- | 51.19 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CE024_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CE024_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CE024_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PKNX2_HUMAN | PKNOX2 | physical | 28514442 | |
GOPC_HUMAN | GOPC | physical | 28514442 | |
STK11_HUMAN | STK11 | physical | 28514442 | |
STRAA_HUMAN | STRADA | physical | 28514442 | |
CHFR_HUMAN | CHFR | physical | 28514442 | |
PBX2_HUMAN | PBX2 | physical | 28514442 | |
PBX3_HUMAN | PBX3 | physical | 28514442 | |
MEIS1_HUMAN | MEIS1 | physical | 28514442 | |
CAB39_HUMAN | CAB39 | physical | 28514442 | |
DCA16_HUMAN | DCAF16 | physical | 28514442 | |
2ABD_HUMAN | PPP2R2D | physical | 28514442 | |
PBX1_HUMAN | PBX1 | physical | 28514442 | |
MK09_HUMAN | MAPK9 | physical | 28514442 | |
PKNX1_HUMAN | PKNOX1 | physical | 28514442 | |
WIPI3_HUMAN | WDR45B | physical | 28514442 | |
AEDO_HUMAN | ADO | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND MASSSPECTROMETRY. |